CN102603842B - 醋酸氢化可的松或其类似物的制备方法 - Google Patents
醋酸氢化可的松或其类似物的制备方法 Download PDFInfo
- Publication number
- CN102603842B CN102603842B CN2012100380590A CN201210038059A CN102603842B CN 102603842 B CN102603842 B CN 102603842B CN 2012100380590 A CN2012100380590 A CN 2012100380590A CN 201210038059 A CN201210038059 A CN 201210038059A CN 102603842 B CN102603842 B CN 102603842B
- Authority
- CN
- China
- Prior art keywords
- reaction
- analogue
- compound
- preparation
- hydrocortisone acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 title claims abstract description 20
- 229960001067 hydrocortisone acetate Drugs 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims abstract description 73
- 150000001875 compounds Chemical class 0.000 claims abstract description 53
- 238000006467 substitution reaction Methods 0.000 claims abstract description 21
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 16
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 14
- 239000010703 silicon Substances 0.000 claims abstract description 14
- 238000006722 reduction reaction Methods 0.000 claims abstract description 13
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 12
- 230000009467 reduction Effects 0.000 claims abstract description 12
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 66
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- 230000001681 protective effect Effects 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 11
- 239000003513 alkali Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 9
- -1 acids pyridinium salt Chemical class 0.000 claims description 8
- 230000001590 oxidative effect Effects 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 150000001408 amides Chemical class 0.000 claims description 6
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 claims description 5
- VYMPLPIFKRHAAC-UHFFFAOYSA-N 1,2-ethanedithiol Chemical compound SCCS VYMPLPIFKRHAAC-UHFFFAOYSA-N 0.000 claims description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- ITKVLPYNJQOCPW-UHFFFAOYSA-N chloro-(chloromethyl)-dimethylsilane Chemical group C[Si](C)(Cl)CCl ITKVLPYNJQOCPW-UHFFFAOYSA-N 0.000 claims description 4
- 229940117975 chromium trioxide Drugs 0.000 claims description 4
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 claims description 4
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052744 lithium Inorganic materials 0.000 claims description 4
- 229940071125 manganese acetate Drugs 0.000 claims description 4
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical group CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 4
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 150000002460 imidazoles Chemical class 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 3
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical group CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims description 3
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 claims description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 2
- 239000004411 aluminium Substances 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229910000085 borane Inorganic materials 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 150000007942 carboxylates Chemical class 0.000 claims description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 238000005502 peroxidation Methods 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000015320 potassium carbonate Nutrition 0.000 claims description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 claims description 2
- 229910001958 silver carbonate Inorganic materials 0.000 claims description 2
- 239000001632 sodium acetate Substances 0.000 claims description 2
- 229960004249 sodium acetate Drugs 0.000 claims description 2
- 235000017281 sodium acetate Nutrition 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 claims description 2
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 claims 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 230000004224 protection Effects 0.000 abstract description 28
- 239000002994 raw material Substances 0.000 abstract description 22
- 238000007254 oxidation reaction Methods 0.000 abstract description 6
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 39
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 28
- 238000003756 stirring Methods 0.000 description 27
- 229910052757 nitrogen Inorganic materials 0.000 description 21
- 238000000967 suction filtration Methods 0.000 description 20
- 238000004128 high performance liquid chromatography Methods 0.000 description 18
- 239000012065 filter cake Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 239000003960 organic solvent Substances 0.000 description 14
- 238000010992 reflux Methods 0.000 description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
- 238000005406 washing Methods 0.000 description 13
- 230000007935 neutral effect Effects 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- FIWILGQIZHDAQG-UHFFFAOYSA-N NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F Chemical compound NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F FIWILGQIZHDAQG-UHFFFAOYSA-N 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 229960000890 hydrocortisone Drugs 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 150000002170 ethers Chemical class 0.000 description 6
- 238000009413 insulation Methods 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 150000008282 halocarbons Chemical class 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 241000223211 Curvularia lunata Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QQIRAVWVGBTHMJ-UHFFFAOYSA-N [dimethyl-(trimethylsilylamino)silyl]methane;lithium Chemical compound [Li].C[Si](C)(C)N[Si](C)(C)C QQIRAVWVGBTHMJ-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Substances OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- JZZIHCLFHIXETF-UHFFFAOYSA-N dimethylsilicon Chemical compound C[Si]C JZZIHCLFHIXETF-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ITRJWOMZKQRYTA-RFZYENFJSA-N Cortisone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O ITRJWOMZKQRYTA-RFZYENFJSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- QABCGOSYZHCPGN-UHFFFAOYSA-N chloro(dimethyl)silicon Chemical compound C[Si](C)Cl QABCGOSYZHCPGN-UHFFFAOYSA-N 0.000 description 1
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
- YGHUUVGIRWMJGE-UHFFFAOYSA-N chlorodimethylsilane Chemical class C[SiH](C)Cl YGHUUVGIRWMJGE-UHFFFAOYSA-N 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229960003290 cortisone acetate Drugs 0.000 description 1
- 150000001887 cortisones Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- HRKQOINLCJTGBK-UHFFFAOYSA-N dihydroxidosulfur Chemical compound OSO HRKQOINLCJTGBK-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical class [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical group OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100380590A CN102603842B (zh) | 2012-02-20 | 2012-02-20 | 醋酸氢化可的松或其类似物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100380590A CN102603842B (zh) | 2012-02-20 | 2012-02-20 | 醋酸氢化可的松或其类似物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102603842A CN102603842A (zh) | 2012-07-25 |
CN102603842B true CN102603842B (zh) | 2013-10-23 |
Family
ID=46521663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100380590A Active CN102603842B (zh) | 2012-02-20 | 2012-02-20 | 醋酸氢化可的松或其类似物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102603842B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103601782A (zh) * | 2013-11-22 | 2014-02-26 | 湖南新合新生物医药有限公司 | 醋酸泼尼松或其类似物的制备方法 |
CN109651477A (zh) * | 2019-02-21 | 2019-04-19 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的脱氢后中间体产品的方法 |
CN109651476A (zh) * | 2019-02-21 | 2019-04-19 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的还原后中间体产品的方法 |
CN109651478A (zh) * | 2019-02-21 | 2019-04-19 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的脱氢后中间体的方法 |
CN109666054A (zh) * | 2019-02-21 | 2019-04-23 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松产品的方法 |
CN109678920A (zh) * | 2019-02-21 | 2019-04-26 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松的方法 |
CN109776643A (zh) * | 2019-02-21 | 2019-05-21 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的醚化后中间体的方法 |
CN109796515A (zh) * | 2019-02-21 | 2019-05-24 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的还原后中间体的方法 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104098642A (zh) * | 2013-04-10 | 2014-10-15 | 沈敬山 | 醋酸可的松的中间体、其制备方法以及其在制备醋酸可的松中的用途 |
CN103641876B (zh) * | 2013-11-22 | 2016-01-06 | 湖南新合新生物医药有限公司 | 可的松醋酸酯的制备方法 |
CN103641881A (zh) * | 2013-11-22 | 2014-03-19 | 湖南新合新生物医药有限公司 | 乌利司他中间体的制备方法 |
CN103641877B (zh) * | 2013-11-22 | 2016-02-10 | 湖南新合新生物医药有限公司 | 氢化可的松中间体的制备方法 |
CN103833814A (zh) * | 2014-03-06 | 2014-06-04 | 浙江仙居君业药业有限公司 | 17羟基-孕甾-4-烯-3,20-二酮-21-醋酸酯的制备方法 |
CN103923145B (zh) * | 2014-04-16 | 2015-04-01 | 江苏远大仙乐药业有限公司 | 一种醋酸可的松重要中间体的制备方法 |
CN104072647B (zh) * | 2014-06-30 | 2017-06-16 | 华东理工大学 | 一类含卤聚合物的制备及其作为氧化反应催化剂催化氧化醇到醛酮的方法 |
CN104610407B (zh) * | 2015-01-27 | 2016-08-17 | 湖南新合新生物医药有限公司 | 醋酸氢化可的松的精制方法 |
CN105017364A (zh) * | 2015-07-06 | 2015-11-04 | 湖南新合新生物医药有限公司 | 甲基泼尼松龙中间体及其制备方法和应用 |
CN105017377B (zh) * | 2015-07-06 | 2018-02-16 | 湖南新合新生物医药有限公司 | 肾上腺皮质激素药物中间体的制备方法 |
CN105820203B (zh) * | 2016-05-09 | 2017-08-08 | 湖南成大生物科技有限公司 | 醋酸氢化可的松的制备方法 |
CN107619423A (zh) * | 2016-07-15 | 2018-01-23 | 天津金耀集团有限公司 | 一种氢化可的松的制备方法 |
CN106866768A (zh) * | 2017-04-25 | 2017-06-20 | 广西万德药业有限公司 | 一种诺美孕酮中间体的合成方法 |
CN109796514B (zh) * | 2019-02-21 | 2020-08-11 | 湖南科瑞生物制药股份有限公司 | 一种由醚化后中间体制备双丙酸阿氯米松的方法 |
CN113493484A (zh) * | 2020-04-02 | 2021-10-12 | 河南利华制药有限公司 | 一种甲基泼尼松及其中间体的制备方法 |
CN112898365B (zh) * | 2021-03-08 | 2023-02-28 | 营口德瑞化工有限公司 | 一种17β-氰基-17α-羟基雄甾-4-烯-3-酮的合成方法 |
CN115260102A (zh) * | 2022-09-13 | 2022-11-01 | 山东斯瑞药业有限公司 | 一种从醋酸阿奈可他硅醚物生产废水中回收咪唑的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2244530B1 (zh) * | 1973-07-27 | 1977-07-01 | Roussel Uclaf | |
GB1536691A (en) * | 1975-02-01 | 1978-12-20 | Lark Spa | 16-methyl-17-bromo-1,4-pregnadien-21-ol-3,20-dione compounds |
US4704358A (en) * | 1982-10-25 | 1987-11-03 | The Upjohn Company | Δ1 -dehydrogenation with heat or air-dried B. cyclooxidans |
US4530795A (en) * | 1984-02-27 | 1985-07-23 | The Upjohn Company | Process for preparation of 16 α-methyl corticoids from Δ16 -steroids |
-
2012
- 2012-02-20 CN CN2012100380590A patent/CN102603842B/zh active Active
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103601782A (zh) * | 2013-11-22 | 2014-02-26 | 湖南新合新生物医药有限公司 | 醋酸泼尼松或其类似物的制备方法 |
CN109651477A (zh) * | 2019-02-21 | 2019-04-19 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的脱氢后中间体产品的方法 |
CN109651476A (zh) * | 2019-02-21 | 2019-04-19 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的还原后中间体产品的方法 |
CN109651478A (zh) * | 2019-02-21 | 2019-04-19 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的脱氢后中间体的方法 |
CN109666054A (zh) * | 2019-02-21 | 2019-04-23 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松产品的方法 |
CN109678920A (zh) * | 2019-02-21 | 2019-04-26 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松的方法 |
CN109776643A (zh) * | 2019-02-21 | 2019-05-21 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的醚化后中间体的方法 |
CN109796515A (zh) * | 2019-02-21 | 2019-05-24 | 湖南科瑞生物制药股份有限公司 | 一种制备双丙酸阿氯米松用的还原后中间体的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102603842A (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102603842B (zh) | 醋酸氢化可的松或其类似物的制备方法 | |
JP6479912B2 (ja) | エステトロール中間体を製造するための方法 | |
JP6196625B2 (ja) | エステトロールを製造するための方法 | |
CN103641878B (zh) | 倍他米松中间体或其类似物的制备方法 | |
AU2016297821B2 (en) | Methods for preparation of bile acids and derivatives thereof | |
KR102527821B1 (ko) | 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 6α-알킬-6,7-다이온 스테로이드 | |
AU2012264602A1 (en) | Process for the production of estetrol intermediates | |
CN102477060B (zh) | 甾体化合物及其制备方法和用途 | |
CA2724130A1 (en) | Methods for preparing 17-alkynyl-7-hydroxy steroids and related compounds | |
CN103601782A (zh) | 醋酸泼尼松或其类似物的制备方法 | |
CN105399791A (zh) | 一种倍他米松中间体的制备方法 | |
CN104311625B (zh) | 一种醋酸氟轻松中间体的制备方法 | |
JP2006508962A (ja) | C−7置換5−アンドロステンの製造方法 | |
CN103641879B (zh) | 泼尼松龙中间体或其类似物的制备方法 | |
CN105017377A (zh) | 肾上腺皮质激素药物中间体的制备方法 | |
CN114315942B (zh) | 一种雌酚酮的合成方法 | |
KR101016608B1 (ko) | 로큐로니움 브로마이드의 제조방법 | |
CN111018936B (zh) | 一种氟维司群有关物质e的合成方法 | |
CN103641876B (zh) | 可的松醋酸酯的制备方法 | |
KR100639655B1 (ko) | 16α,17α-에폭시프레그네놀론으로부터4,17(20)-프로스타디엔-3,16-디온의 제조방법 및 이를제조하기 위한 중간체 | |
CN111247160A (zh) | 一种胆酸类化合物的制备方法 | |
CN114437169B (zh) | 一种屈螺酮关键中间体溴代物的合成方法 | |
CN114133421B (zh) | 一种β-鼠胆酸的制备方法 | |
CN103641877A (zh) | 氢化可的松中间体的制备方法 | |
CN101676296B (zh) | 制备21位羧酸酯甾体化合物的方法及使用该方法制备的甾体化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HUBEI XINHE NEW BIOLOGICAL MEDICINE CO., LTD. Free format text: FORMER OWNER: HUNAN NORCHEM PHARMACEUTICAL CO., LTD. Effective date: 20130724 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 410329 CHANGSHA, HUNAN PROVINCE TO: 415000 CHANGDE, HUNAN PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130724 Address after: 415000 Hunan city of Changde Province Jin city Dan Jin Road No. 2 ICBC City branch of the West Building 3 Applicant after: HUNAN XINHEXIN BIOLOGICAL MEDICINE Co.,Ltd. Address before: 410329 Hunan province Changsha city Liuyang City Dong Yang Zhen Liuyang Biomedical Park Road No. 19 building branch lotus Applicant before: HUNAN NORCHEM PHARMACEUTICAL Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of hydrocortisone acetate or analogue thereof Effective date of registration: 20150619 Granted publication date: 20131023 Pledgee: Changde City Xin Science and technology Company limited by guarantee Pledgor: HUNAN XINHEXIN BIOLOGICAL MEDICINE Co.,Ltd. Registration number: 2015430000013 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160606 Granted publication date: 20131023 Pledgee: Changde City Xin Science and technology Company limited by guarantee Pledgor: HUNAN XINHEXIN BIOLOGICAL MEDICINE Co.,Ltd. Registration number: 2015430000013 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of hydrocortisone acetate or analogue thereof Effective date of registration: 20160706 Granted publication date: 20131023 Pledgee: Changde Caixin technology Company limited by guarantee Pledgor: HUNAN XINHEXIN BIOLOGICAL MEDICINE Co.,Ltd. Registration number: 2016430000016 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170804 Granted publication date: 20131023 Pledgee: Changde Caixin technology Company limited by guarantee Pledgor: HUNAN XINHEXIN BIOLOGICAL MEDICINE Co.,Ltd. Registration number: 2016430000016 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of hydrocortisone acetate or its analogues Effective date of registration: 20230613 Granted publication date: 20131023 Pledgee: Hunan Bank Co.,Ltd. Jinshi Branch Pledgor: HUNAN XINHEXIN BIOLOGICAL MEDICINE Co.,Ltd. Registration number: Y2023980043801 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230905 Granted publication date: 20131023 Pledgee: Hunan Bank Co.,Ltd. Jinshi Branch Pledgor: HUNAN XINHEXIN BIOLOGICAL MEDICINE Co.,Ltd. Registration number: Y2023980043801 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |